Functional classification of heart failure

What it is and when to use it

The NYHA (New York Heart Association) Functional Classification grades the severity of heart failure symptoms based on the limitation of physical activity and the onset of dyspnea, fatigue, or palpitations. It is assigned clinically, without the need for additional testing, and is used to stratify patients, guide treatment intensity, and monitor therapeutic response over time. It is the symptom classification recommended by the 2021 ESC guidelines for acute and chronic heart failure and by the 2022 AHA/ACC/HFSA guidelines.

How to interpret it

Class I: no limitation of physical activity; ordinary activity does not cause symptoms. Class II: slight limitation; comfortable at rest, but ordinary physical activity causes dyspnea, fatigue, or palpitations. Class III: marked limitation; comfortable at rest, but less-than-ordinary activity already provokes symptoms. Class IV: unable to carry out any physical activity without discomfort; symptoms occur at rest or with minimal exertion. A higher class is associated with worse prognosis and higher mortality, and many therapeutic indications (for example, certain devices or drugs) are defined according to NYHA class.

Limitations and when not to use it

The classification was developed and validated in patients with heart failure and is not applicable as a diagnostic tool in an asymptomatic population. It is a subjective assessment with substantial inter-observer variability and low reproducibility, and it may fluctuate depending on the day or the moment of evaluation. It does not measure ejection fraction, ventricular function, natriuretic peptides, or the underlying cause of heart failure, and it should not be confused with the AHA/ACC stages A-D, which reflect the structural progression of disease and are not reversible.

Frequently asked questions

What is the difference between NYHA class and the AHA/ACC stages A-D?

NYHA class describes current symptoms and can improve or worsen with treatment, whereas the AHA/ACC stages A-D reflect the structural progression of disease and only advance, never regress.

Can NYHA class be reversed with treatment?

Yes; unlike structural staging, functional class can improve with optimal heart failure therapy and worsen with decompensation.

Is any test needed to assign NYHA class?

No; it is assigned solely from the history and clinical assessment of functional limitation, without the need for echocardiography or laboratory work.